sexual health
Rollout of world-first gonorrhoea vaccine programme begins under NHS
August 8, 2025Medical Communications 10 Year Health Plan, Genito-Urinary system, Infections and infestations, NHS, gonorrhoea, sexual health, sexually transmitted infections, vaccination
From 4 August, sexual health clinics in England have been able to offer a free vaccine – the 4CMenB vaccine …
Freya Pharma launches phase 2 study of therapy for female sexual dysfunction
August 5, 2025Research and Development Female Sexual Interest/Arousal Disorder (FSIAD), Freya Pharma Solutions, Genito-Urinary system, sexual health
Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …
GSK shares results from phase 3 trial for gonorrhoea treatment
April 18, 2024Research and Development GSK, Reproductive health, clinical trial, gonorrhoea, sexual health
GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential first-in-class oral antibiotic for the …
Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds
February 5, 2020Research and Development AIDS, HIV, STDs, STIs, UK, sexual health
The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …
GSK drops herpes vaccine
October 4, 2010Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health
Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …
Digital Pharma: UK health clinic first for Pfizer
July 28, 2010Medical Communications Digital Pharma blog, Pfizer, digital patients, digital pharma med coms, disease awareness campaigns, sexual health
Men in the UK can now go online for confidential advice and information about any health problem through a unique …
Bayer Schering’s contraceptive patch enters phase III
May 5, 2009Research and Development, Sales and Marketing Bayer, sexual health
Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
